Chip Herring

Chip Herring, MBA, has extensive experience in the pharmaceutical and medical device industries, specializing in ophthalmic products and patient care. Currently serving as the Regional Business Director at ImprimisRx since January 2022, Chip manages sales and distribution of FDA-approved medications across a four-state region. Previously, Chip held positions as Key Account Manager at EyePoint Pharmaceuticals, focusing on training for Dexycu administration, and as Territory Manager at Bausch + Lomb. Prior experience includes specialty sales roles at Omeros Corporation, where Chip contributed to the launch of Omidria, and business development at Allergan, overseeing a cosmetic product portfolio. Chip holds an MBA from Methodist University and a BS in Business Administration from the University of North Carolina at Pembroke.